Search Results - "Tang, Huoling"

Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models by Chen, Wei, Tang, Huoling, Liu, Hongying, Long, Long, Gong, Zehui, Zheng, Jianquan, Chi, Mugen, Xie, Yunde, Zheng, Zhibing, Li, Song, Wang, Lili

“…MJ15, a novel cannabinoid CB(1) receptor selective antagonist was discovered. In receptor binding assays, MJ15 displayed a high affinity for rat cannabinoid…”
Get full text

A first-in-human, open label, multiple dose, dose escalation, and cohort expansion phase I study to investigate the safety, tolerability, pharmacokinetics and antitumor activity of BB-1701 in patients with locally advanced/metastatic HER2-expressing solid tumors by Ma, Fei, Xu, Nong, Tang, Huoling, Zhou, Yuhong, Wei, Ziping, Munster, Pamela N.

“…3029 Background: BB-1701 is an antibody-drug conjugate consisting of a humanized IgG1κ monoclonal antibody and eribulin. When BB-1701 targets HER2-expressing…”
Get full text

Abstract RF02-05: Report on Cohort Expansion of Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of BB-1701 in Patients with Locally Advanced/Metastatic HER2 Low Breast Cancer by Ma, Fei, Munster, Pamela, Guan, Xiaoxiang, Wang, Jingfen, Yao, Herui, Hamilton, Erika, Wang, Xian, Shi, Yehui, Liang, Xinjun, Xu, Nong, Tang, Huoling, Zhou, Yuhong, Wei, Ziping

“…Abstract Background: BB-1701 is an antibody-drug conjugate (ADC) consisting of a humanized IgG1κ monoclonal anti-HER2 antibody with the same sequence as…”
Get full text

Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study by Kao, Jia‐Horng, Yu, Min‐Lung, Chen, Chi‐Yi, Peng, Cheng‐Yuan, Chen, Ming‐Yao, Tang, Huoling, Chen, Qiaoqiao, Wu, Jinzi J

“…Background and Aim The need for all‐oral hepatitis C virus (HCV) treatments with higher response rates, improved tolerability, and lower pill burden compared…”
Get full text

Novel selective antagonist of the cannabinoid CB sub(1) receptor, MJ15, with prominent anti-obesity effect in rodent models by Chen, Wei, Tang, Huoling, Liu, Hongying, Long, Long, Gong, Zehui, Zheng, Jianquan, Chi, Mugen, Xie, Yunde, Zheng, Zhibing, Li, Song, Wang, Lili

“…MJ15, a novel cannabinoid CB sub(1) receptor selective antagonist was discovered. In receptor binding assays, MJ15 displayed a high affinity for rat…”
Get full text

Novel selective antagonist of the cannabinoid CB 1 receptor, MJ15, with prominent anti-obesity effect in rodent models by Chen, Wei, Tang, Huoling, Liu, Hongying, Long, Long, Gong, Zehui, Zheng, Jianquan, Chi, Mugen, Xie, Yunde, Zheng, Zhibing, Li, Song, Wang, Lili

“…MJ15, a novel cannabinoid CB 1 receptor selective antagonist was discovered. In receptor binding assays, MJ15 displayed a high affinity for rat cannabinoid CB…”
Get full text